开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2023-12-30 ssssdsfwaefwa 来自四川省

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：外科
经验分享：#Meta分析# 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。

82 0

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2023-02-16 ms7000001279733416 来自山东省

请问该杂志接受纯生信文章么。

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2022-06-25 流星雨87

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肝脏;缺血再灌注
经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。

132 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2019-02-03 医路顺风2971

请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表:
已接受

倔强的骆驼 2019-01-04 00:00:00 发表: 已接受

233 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2019-12-22 1252ce9em81(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0
经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。

202 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2022-06-10 147b84bdm47(暂无昵称)

偏重的研究方向：外科
经验分享：under review快2个月了，发邮件询问没回复，这正常不

145 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2020-10-28 1251a7c4m42暂无昵称

请问各位，这个杂志的版权**协议在哪里下载？

230 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

SCI期刊是如何分区的？

130 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2021-12-27 衣谷

选刊时需结合IF进行吗？

160 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2178071, encodeId=809221e8071b0, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：外科 经验分享：<a href='/topic/show?id=fd57116110e' target=_blank style='color:#2F92EE;'>#Meta分析#</a> 10.24 manuscript submitted 10.24 with journal administrator 10.27 with editor 11.02 with editor 11.02 out for review 12.19 accept subject to minor revision 12.19 revised manuscript submitted 12.19 with journal administrator 12.21 with editor 12.29 accepted 总的来讲虽然没有网页上说的平均38天那么快，还是一次愉快的投稿体验，review过程中状态没有出现变化，都有点想发邮件咨询了，决定两个月没消息的话再问，很突然返修回来了，最后如果不是碰到圣诞节的话应该会在两个月内，有合适的稿件会再投的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11611, encryptionId=fd57116110e, topicName=Meta分析)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Sat Dec 30 04:28:32 CST 2023, time=2023-12-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2115000, encodeId=29952115000a2, content=请问该杂志接受纯生信文章么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22b35424096, createdName=ms7000001279733416, createdTime=Thu Feb 16 23:52:54 CST 2023, time=2023-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1228646, encodeId=190912286468b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肝脏;缺血再灌注 经验分享：历经几次查重修改及一次润色的返修，最终接收，希望影响因子不要降太多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=502a1955530, createdName=流星雨87, createdTime=Sat Jun 25 20:45:16 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566457, encodeId=33f156645ed2, content=请问杂志的引文格式从哪里找是Vancouver吗？倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, beContent=倔强的骆驼 2019-01-04 00:00:00 发表: 已接受, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTInw23BfgokE5rxHbZzPvaYPiatrJDDDjqmibSicfoicWDsggsZktYYbZXwBNaIiaBg4NKOVuPxAic8IXSA/132, createdBy=ff212336035, createdName=医路顺风2971, createdTime=Sun Feb 03 00:00:00 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581982, encodeId=4a5c58198299, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度很快，10.29投稿，11.31大修，3个审稿人提的问题很严谨，问题不算多，修稿时间有25天，12.19修回，12.20接收。总体感觉速度不错，效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/25/ddde730b49bcbe3f6d7ce970189dde9c.jpg, createdBy=29822545104, createdName=1252ce9em81(暂无昵称), createdTime=Sun Dec 22 17:44:00 CST 2019, time=2019-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225737, encodeId=66d01225e3745, content=偏重的研究方向：外科 经验分享：under review快2个月了，发邮件询问没回复，这正常不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a62d5239045, createdName=147b84bdm47(暂无昵称), createdTime=Fri Jun 10 22:52:48 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895155, encodeId=5b9f89515549, content=请问各位，这个杂志的版权**协议在哪里下载？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=57772539327, createdName=1251a7c4m42暂无昵称, createdTime=Wed Oct 28 20:02:48 CST 2020, time=2020-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093460, encodeId=08ab109346007, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093459, encodeId=964210934590f, content=选刊时需结合IF进行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945501, encodeId=5da4945501f9, content=这个杂志的版权**证书在哪里啊，有人知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKJn00QRPUIQRIfRn1gJOYBXibwFW4ibQuO09ObUInlL9wHCMQW2ADGW7Oibhr7Hqw6TN04s4wQ2z4Qg/132, createdBy=2b8d2258604, createdName=aciding, createdTime=Thu Mar 04 17:08:01 CST 2021, time=2021-03-04, status=1, ipAttribution=)]

2021-03-04 aciding

这个杂志的版权**证书在哪里啊，有人知道吗

179 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务